Format

Send to

Choose Destination
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):E125-E134. doi: 10.1002/ccd.27483. Epub 2018 Jan 11.

Impact of pre-procedural hyponatremia on clinical outcomes after transcatheter aortic valve replacement: A propensity-matched analysis.

Author information

1
Department of cardiology, Toyohashi Heart Center, Toyohashi, Japan.
2
Department of cardiology, Nagoya Heart Center, Nagoya, Japan.
3
Department of cardiology, Sendai Kosei Hospital, Sendai, Japan.
4
Department of cardiology, New Tokyo Hospital, Chiba, Japan.
5
Department of cardiology, Saiseikai Yokohama City Eastern Hospital, Yokohama, Japan.
6
Department of cardiology, Syonan Kamakura General Hospital, Kanagawa, Japan.
7
Department of cardiology, Kokura Memorial Hospital, Kokura, Japan.
8
Department of cardiology, Teikyo University School of Medicine, Tokyo, Japan.
9
Department of cardiology, Keio University School of Medicine, Tokyo, Japan.

Abstract

BACKGROUND:

Hyponatremia is associated with the increased risk of early and late mortality in patients with cardiac disease. This study aimed to assess the prognostic value of hyponatremia in patients who had undergone transcatheter aortic valve replacement (TAVR).

METHODS:

We investigated 1,215 consecutive patients (mean age: 84.4 ± 5.0 years) who underwent TAVR using data from the Optimized CathEter vAlvular iNtervention (OCEAN)-TAVR Japanese multicenter registry. Hyponatremia was defined as a serum sodium value less than 135 mEq/L. The baseline characteristics, procedural outcomes, all-cause, cardiovascular, and non-cardiovascular mortality were compared between patients with hyponatremia (n = 106, 8.7%) and without hyponatremia (n = 1,109, 91.3%). A propensity-matching analysis was used to adjust for the non-uniform patient characteristics.

RESULTS:

Differences in the baseline characteristics were observed between the two groups regarding the prevalence of pulmonary disease (37.7% vs. 28.9%, P = 0.04) and the performance of non-elective TAVR (10.4% vs. 4.2%, P = 0.01), although these were minimized in the matched model. The 30-day mortality rates differed between the two groups (7.6% vs. 1.4%, P < 0.001). During a mean follow-up of 330 days, the all-cause and cardiovascular mid-term mortality were higher in the hyponatremia group than in the non-hyponatremia group (log-rank test: P = 0.0047, and P < 0.001, respectively). The three findings above were not attenuated in the propensity-matched model (P < 0.001, P = 0.0044, and P = 0.014, respectively). In contrast, there was no difference in non-cardiovascular mortality between the two groups in both the overall and matched model (P = 0.40 and P = 0.13, respectively).

CONCLUSIONS:

Pre-procedural hyponatremia may be a useful marker for predicting early and mid-term clinical outcomes after TAVR.

KEYWORDS:

clinical outcomes; hyponatremia; transcatheter aortic valve replacement

PMID:
29322611
DOI:
10.1002/ccd.27483

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center